Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 358

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Usefulness of anti‐p155 autoantibody for diagnosing cancer‐associated dermatomyositis: A systematic review and meta‐analysis

Trallero‐Araguás, Ernesto, Rodrigo‐Pendás, Jose Ángel, Selva‐O'Callaghan, Albert, Martínez‐Gómez, Xavier, Bosch, Xavier, Labrador‐Horrillo, Moisés, Grau‐Junyent, Josep Maria, Vilardell‐Tarrés, Miquel·2012·Arthritis & Rheumatism

Abstract

Objective: Anti‐p155 autoantibody, which was recently described in adult patients with dermatomyositis (DM), seems to be associated with cancer in this population. We performed a systematic review and meta‐analysis to ascertain the accuracy of anti‐p155 testing for the diagnosis of cancer‐associated myositis. Methods: We searched relevant databases, with no restrictions on study design or language, for original studies that included adult patients with probable/definite DM or amyopathic DM who were evaluated for neoplasm and anti‐p155 status. Pooled sensitivity and specificity were calculated using a bivariate model. We computed the diagnostic odds ratio (OR), likelihood ratios (LRs) for positive and negative test results, positive and negative predictive values, and the summary receiver operating characteristic (SROC) curve. Statistical heterogeneity between studies was assessed using the I 2 statistic, and 95% confidence intervals (95% CIs) were computed for the parameters studied. Results: Six studies including a total of 312 adult patients with DM were selected. The pooled sensitivity of anti‐p155 for diagnosing cancer‐associated DM was 78% (95% CI 45–94%), and specificity was 89% (95% CI 82–93%). The diagnostic OR was 27.26 (95% CI 6.59–112.82), and LRs for positive and negative test results were 6.79 (95% CI 4.11–11.23) and 0.25 (95% CI 0.08–0.76), respectively. Heterogeneity was substantial except with regard to the LR for a positive test result. The area under the SROC curve was 0.91 (95% CI 0.88–0.93). Taking the pooled prevalence of 17% as pretest probability, anti‐p155 had a positive predictive value of 58% and a negative predictive value of 95%. Conclusion: Our findings indicate that anti‐p155 autoantibody determination is useful for diagnosing cancer‐associated myositis and guiding disease management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.33379

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 358

Metadata

Authors
Trallero‐Araguás, E., Rodrigo‐Pendás, J. Á., Selva‐O'Callaghan, A., Martínez‐Gómez, X., Bosch, X., Labrador‐Horrillo, M., Grau‐Junyent, J. M., & Vilardell‐Tarrés, M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2012-01-27
Volume
64
Issue
2
Pages
523-532
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2044606833
Cited by
358
References
18
FWCI
1.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Usefulness of anti‐p155 autoantibody for diagnosing cancer‐associated dermatomyositis: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1002/art.33379
The paper
Trallero‐Araguás, E., Rodrigo‐Pendás, J. Á., Selva‐O'Callaghan, A., Martínez‐Gómez, X., Bosch, X., Labrador‐Horrillo, M., Grau‐Junyent, J. M., & Vilardell‐Tarrés, M. (2012). Usefulness of anti‐p155 autoantibody for diagnosing cancer‐associated dermatomyositis: A systematic review and meta‐analysis. Arthritis & Rheumatism. https://doi.org/10.1002/art.33379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.